ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
Insider CIK 1280238 · CMRX · MGNX 10% owner · AEGR 10% owner · CARA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 89,227 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 1,328,604 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 32,742 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 158,741 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 2,363,654 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 58,250 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 6,940 | $11.00 | $76.3K | 117,760 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 1,118,675 | — | $0 | 1,118,675 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 531,442 | — | $0 | 1,650,117 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 103,330 | $11.00 | $1.14M | 1,753,447 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 2,547 | $11.00 | $28.0K | 43,212 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 13,097 | — | $0 | 40,665 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 27,568 | — | $0 | 27,568 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 35,691 | — | $0 | 110,820 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 75,129 | — | $0 | 75,129 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 18,728,346 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 12,328,024 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 3,833,767 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | X Exercise deriv | 2013-10-16 | 2013-10-18 | 287,533 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 204,206 | — | $0 | 1,998,195 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 1,137,332 | — | $0 | 1,137,332 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 656,657 | — | $0 | 1,793,989 | SEC↗ |
| MGNX MACROGENICS INC | X Exercise | 2013-10-16 | 2013-10-18 | 15,314 | — | $0 | 2,013,509 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 688,729 | — | $0 | 1,515,203 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 550,982 | — | $0 | 2,161,829 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 826,474 | — | $0 | 826,474 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 3,160 | $18.67 | $59.0K | 56,190 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 128,229 | $18.67 | $2.39M | 2,280,197 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-16 | 2012-10-17 | 8,611 | $18.67 | $160.8K | 153,131 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 1,371 | $17.54 | $24.0K | 59,350 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 55,626 | $17.54 | $975.7K | 2,408,426 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2012-10-15 | 2012-10-17 | 3,736 | $17.54 | $65.5K | 161,742 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 1,955,991 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,444,990 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,933,986 | — | $0 | 0 | SEC↗ |